- Open Access
Investigating the synchronization of hippocampal neural network in response to acute nicotine exposure
© Akkurt et al; licensee BioMed Central Ltd. 2010
Received: 3 April 2009
Accepted: 13 July 2010
Published: 13 July 2010
Previous studies suggested that γ oscillations in the brain are associated with higher order cognitive function including selective visual attention, motor task planning, sensory perception, working memory and dreaming REM sleep. These oscillations are mainly observed in cortical regions and also occur in neocortical and subcortical areas and the hippocampus. In this paper, we investigate the influence of acute exposure to nicotine on the complexity of hippocampal γ oscillations.
Using the approximate entropy method, the influence of acute nicotine exposure on the hippocampal γ oscillations was investigated. The hippocampal γ oscillations have been generated in response to the 100 Hz stimulus and isolated using the visual inspection and spectral analysis method. Our central hypothesis is that acute exposure to nicotine significantly reduces the complexity of hippocampal γ oscillations. We used brain-slice recordings and the approximate entropy method to test this hypothesis. The approximate entropy (complexity) values of the hippocampal γ oscillations are estimated from the 14 hippocampal slices. Our results show that it takes at least 100 msec to see any hippocampal activities in response to the 100 Hz stimulus. These patterns noticeably changed after 100 msec until 300 msec after the stimulus Finally, they were less prominent after 300 msec. We have analyzed the isolated hippocampal γ oscillations (between 150 and 250 msec after the stimulus) using the approximate entropy (ApEn) method. Our results showed that the ApEn (complexity) values of hippocampal γ oscillations during nicotine exposure were reduced compared to those of hippocampal γ oscillations during control, and washout. This reduction was much more significant in response to acute nicotine exposure (p < 0.05) compared to those during control and washout conditions. These results suggest that the neural firing becomes regular and the hippocampal networks become synchronized in response to nicotine exposure.
Nicotine, C10H14N2, a tertiary amine compound, is a very toxic, light yellow alkaloid which is produced in tobacco plants as a result of the leaves' being damaged [1, 2]. The roots of the damaged plants synthesize nicotine as a reaction to hormones released by the damaged tissue and then transport it to the leaves. Nicotine is stored in concentrations of 2-8 percent by weight in the leaves which becomes the primary psychoactive ingredient in tobacco smoke. It is very soluble in water and nonpolar solvents. It is absorbed rapidly by the body, either through the skin or smoking, crosses the blood-brain barrier and stimulates nicotinic-cholinergic receptors of the CNS, causing an increase in heart rate, blood pressure and some cognitive functions in humans and experimental animals .
Nicotine exerts its effects through the activation of nicotinic acetylcholine receptors (nAChRs) in the multiple areas of the brain such as hippocampus, amygdala and prefrontal cortex (PFC) . These receptors are ion channels and their locations are very important as far as the understanding of their physiological impact on neuronal activity is concerned [4, 5]. A series of studies have pointed out the crucial role these areas play in working memory function. Particularly, stimulation of the (nACHRs) in the hippocampus was proven critical for optimal memory performance [5, 6].
The mounting evidence suggests that the synaptic plasticity, such as long-term potentiation (LTP), takes part during the learning and memory process. LTP has been investigated in detail in the Shaffer collateral CA1 region of the hippocampus where nicotine enhances LTP induction and modulates the synaptic plasticity--thereby playing a crucial role on attention performance [7, 8].
It has been proposed that higher cognitive functions, such as learning, memory, attention and exploratory behavior, could be represented in the CA1 region of the hippocampal area of the brain by a distributed neuronal network synchronization on an oscillatory mode as the gamma-band or 40 Hz (30-80 Hz) oscillations . Gamma oscillations appear primarily in the neocortex, hippocampus, thalamus and related structures. In the hippocampus, they are generated by the entrainment of populations of mutually interconnected interneurons and can be stimulated by brief high-frequency tetanic stimuli to the Schaffer collateral CA1 pathway in hippocampal slice preparations [9–11].
There is a strong link between nicotine administration, neuronal nicotinic systems and higher cognitive functions evident from many studies in rodents, primates, zebrafish and humans [12–15]. Fries et al suggested that nicotine plays an important role in regulating beta oscillations which are associated with higher cognitive functions. Gray et al suggested that nicotine influences cognition by enhancing synaptic transmission. Radial-arm maze is an important tool for the testing of the working memory in rats and it has shown a significant improvement in this memory type with both acute and chronic nicotine treatments [14–16]. However, nicotine-induced improvement in attention in rats seemed to be strain-dependent. Sprague-Dawley rats showed better performance than the Lister hooded rats in attention tests, which suggested that there may be crucial, strain-related differences in the mechanisms of the nicotinic receptors--or neuronal systems related to higher cognitive functions--and nicotine reinforcement [17, 18].
In non-smoking adults with ADHD (attention deficit hyperactivity disorder), nicotine seemed to improve attention . In Alzheimer's Disease (AD), which is characterized by loss of cognitive functioning, there is strong evidence that nicotinic receptors play an important role in the pathogenesis of the disorder. Postmortem evaluations of the brains of AD patients have shown a substantial loss in nicotinic receptors in cortex and striatum. According to the growing amount of findings, accumulation of amyloid plaques--which are the baseline indicator in the brain for AD--is interfered by nicotine, which is very promising for the future of AD patients [20, 21].
In many studies on the effect of nicotine in Schizophrenic patients, despite many positive findings for attention and spatial processing, a majority of the tests related to the measurements of memory functioning gave negative results . An important body of evidence suggests that, nicotinic receptors play a role in the pathophysiology of Parkinson's Disease (PD), revealing that smoking may provide some protection against the onset of PD. However, a wider rage of intense studies needs to be performed before drawing any significant conclusions .
There are some studies indicating nicotine's positive effects in improving cognitive functioning in individuals with Tourette's and Down's syndromes. In spite of promising results, these studies have been limited and more thorough research is needed in these cases . In the current study, we have investigated the effect of nicotine on the complexity of the neurons and the activity of the gamma oscillations in the Schaffer CA1 cell line on the hippocampal slices.
Preparation of slices
All experimental protocols were approved by the Institutional Animal Care and Use Committee of Arizona State University; Furthermore, all experiments were carried out in accordance to such protocols. In this experiment, Sprague Dawley rats age 23-36 days old were anesthetized by isoflurane then immediately decapitated. Without delay the brain was removed and placed in chilled (4°C) artificial cerebrospinal fluid (ACSF). The ACSF solution consisted of the following 135 mM NaCl, 3 mM KCl, 16 mM NaHCO3, 1 mM MgCl, 1.25 mM NaH2PO4, 2 mM CaCl2, and 10 mM Glucose . The above solution was continuously bubbled with carbogen (95-5% Oxygen - Carbon Dioxide gas mixture). This solution was chosen because of its success in prior work as described in . The Brain tissue was cold sliced using a vibratome (Vibratome 1000, Vibratome Co., St. Louis, MO, USA) while immersed in chilled ACSF bulled with carbogen. Coronal sections at 400 μm of the chilled brain tissue were made using the vibratome followed by transverse sectioning to create tissue containing hippocampus and entorhinal cortex.
All Sectioning was done while the tissue was under the protection of the chilled ASCF. The cut slices were immediately transferred to a incubation chamber containing ACSF, where the atmosphere was 95% Oxygen and 5% Carbon Dioxide. The Slices were incubated in this chamber at 24°C for 1 hour prior to recording. After the incubation period a slice was transferred to a liquid-air interface chamber to begin recording (Fine Science Tools Inc., Foster City, CA, USA). The slice was suspended on a nylon mesh in the recording chamber where ACSF bubbled with carbogen continually flowed past the slice at a rate of 2-2.5 ml/min. Recording chamber temperature was closely monitored and regulated by a feedback circuit set at 34 ± .3°C. The slice was allowed 15 minutes of rest before any stimulation was made. In this experiments we used (-) nicotine (Sigma Chemical Co., St. Louis, MO).
Using borosilicate glass electrodes (borosilicate micropipettes, WPI, Sarasota, FL) with a pulled tip of about 1 μm, extracellular field potential recordings were made on the stratum pyramidale of the CA1 cell layer. The micropipette was filled with a standard 2 M NaCl solution . The slices were stimulated with double intensity (2 times threshold, 2 T) which is approximately between 8 V and 14 V. Double intensity (2 T) was chosen due to its ability to induce γ oscillations. Once the stimulation voltage was set for a particular slice it was not changed for the remainder of the experiments on that slice. The stimulating voltage was delivered via bipolar twisted platinum wire electrode on the Schaffer collaterals. In order to induce tetanus, the stimulation signal is changed from a single pulse lasting a 100 μ second to a train of 100 Hz signal lasting 200 ms delivered by a model 2100 A-M Systems Isolated Pulse Stimulator (Carlsborg, WA) [25–30]. The tetanic stimulation level is determined by the threshold level voltage that must be applied to the Schaffer collaterals to elicit a response. In order to induce γ oscillations, the stimulation intensity needs to be set at above threshold and double intensity stimulation was used. Signals were recorded using an Axoclamp 900A (Axon Instruments, Inc., Union City, CA, USA) amplifier. Prior to each drug experiment a single stimulus (8-14 V, 100 μs) was delivered to the slice to insure the slice was viable and the recording and stimulating electrodes were in the optimum positions to record synaptic transmission. Once the optimum electrode placement was determined, signal stability was insured by recording anywhere from 20-60 min prior to actual nicotine administration. After the recordings were stabilized the chemical was started and tetanic stimulations were applied every 10 minutes. The concentration of the nicotine used in this experiment was 100 μ Molar. Only a single concentration was used because previously it was shown by Song et al. that 100 μ Molar was the minimum dose that would cause tetanic beta oscillations. Nicotine was dissolved in ACSF and delivered to the slice at the same rate as standard ACSF solution without drug [27–30].
Data acquisition and analysis
All signals were recorded with pClamp 10.2 via Axon Digidata 1440A (Axon Instruments, Inc., Union City, CA, USA). The recording parameters were set such that the sampling frequency was 100 kHz and low pass filtered with a cut off at 1 kHz. All signals were then transferred to a PC for later analysis. Offline analysis was done on Matlab using various tools such as approximate entropy and Matching Pursuit techniques.
Quantitative changes in the complexity of a signal are traditionally quantified using tools such as nonlinear dynamical system analysis methods. These traditional complexity measures work well when signals are long in duration as they are length dependent[31–33]. For biological signals with short signal durations of 100-5000 points, these traditional complexity measures that measure signal irregularity don't work well. A statistically efficient measure to quantify the irregularity of a signal has been formulated to overcome these shortcomings of these previous complexity measures, commonly known as approximate entropy [31–33].
To analyze the field potential recordings generated by the hippocampal CA1 layer approximate entropy (ApEn) was ultimately used. ApEn is a statistical measure that both smoothens the transient interference and suppresses the influence of noise by properly adjusting the algorithms parameters. This said irregularity measure can be applied both to deterministic and stochastic signals [33, 34]. Considering that the outputs of a biological systems can be rather complex and could be either deterministic or stochastic or both, thus it is crucial that this complexity measure be able to handle both signal types. The algorithm summarizes a time series into a non-negative number, with higher values representing more irregular systems .
assuming that all the differences between the corresponding elements will be less than the threshold r.
The parameter m is the embedding dimension of the analyzed signals and the parameter r is the threshold to suppress the noise in the signal. Throughout this study we have chosen m = 2 as described in previous works . The parameter r can be chosen as 0.1 SD(x(i)), where SD(x(i)) represents the standard deviation of the original signal x(i).
Our results suggest that the complexity values the hippocampal oscillations during control were more or less the same and high during washout periods. However, the mean complexity value of the hippocampal oscillations in response to nicotine exposure were reduced compared to those of control and washout periods (p < 0.05). These results furthermore suggest that the hippocampal γ oscillations in response to nicotine exposure are unique and indicate the emergence of more synchronization of the hippocampal neural networks since hippocampal neural firings become regular and deterministic processes in response to the 100 Hz stimulus.
Discussion and conclusion
It has been widely reported that γ oscillations in the brain are associated with higher order cognitive function including selective visual attention, motor task planning, sensory perception, working memory and dreaming REM sleep. These oscillations are mainly observed in cortical regions and also occur in neocortical and subcortical areas and the hippocampus. Hippocampal neurons play a critical role in information processing and decision making.
Although many components of tobacco smoke are harmful to the brain, and cardiorespiratory systems, nicotine has been found to be useful for the improvement of cognitive functions including working memory and executive function. Furthermore, it has been found to be neuroprotective . It has been widely reported that acute exposure to nicotine improves vigilance, selective attention, memory, and executive function in human and animals. The activation of the cholinergic system and subsequent downstream effects on neurotransmitter release including dopamine and serotonin are responsible for this .
In addition, the nicotine was also proposed for the treatment of Alzheimer's disease (AD) and schizophrenia. The nicotinic-cholinergic system was suggested as a novel therapeutic mechanism for treatment in schizophrenia. Several cholinergic receptor agonists were proposed to characterize central nervous system cholinergic function and as potential candidates for the treatment of schizophrenia as well as dementia of the Alzheimer's type. In addition, the alpha7 nicotinic receptor agonists have also been found to be effective on learning and memory in animals. Thus, these alpha7 nicotinic receptor agonists appear to be excellent candidates for the treatment of impaired sensory gating, cognitive deficits and negative symptoms in people with schizophrenia [36–39].
Martin et al discussed a novel model of nicotinic-cholinergic dysfunction which may be responsible for the impairment of sensory gating in schizophrenia and the related neurobiological and genetic mechanisms as well as the treatment of this disease with the use of nicotine, clozapine and the potential place of the new alpha7 nicotinic receptor agonists [39, 40].
In this paper, we focus only on the influence of nicotine exposure on the complexity of hippocampal γ oscillations. We used a nonlinear dynamics approach for data analysis since the γ oscillations reflect the integrated properties of the underlying dynamics of the hippocampal neural network and therefore exhibit highly complex/irregular features. Specifically, the approximate entropy is a computationally efficient complexity analysis method that is able to produce accurate estimations of the complexity of the biological signals complexity (irregularity). Our study suggests that that the sequence of 100 Hz stimulations triggered a response consisting of γ oscillations (30-120 Hz) 150 msec after the application of the stimulus. The most striking observation was the reduction of complexity values of isolated hippocampal γ oscillations in response to acute nicotine exposure. It furthermore suggests the strong synchronization of hippocampal neural network in the mid phase (gamma oscillation segment) in response to acute nicotine exposure. But, the reorganization of the hippocampal network was a reversible process since all the complexity values were restored after the washout period.
The authors wish to thank Dr Jie Wu for his advice and help to build our experimental set-up.
- Brautbar N: Direct effects of nicotine on the brain: evidence for chemical addiction. Archives of Environmental Health 1995, 1: 263. 10.1080/00039896.1995.9935952View ArticleGoogle Scholar
- Heishman SC, Taylor RC, Henningfield JE: Nicotine and smoking: a review of effects on human performance. Exp Clin Psychopharmacol 1994, 2: 1-51.Google Scholar
- Rusted JM, Newhouse PA, Levin ED: Nicotinic treatment for degenerative neuropsychiatric disorders such as alzheimer's disease and parkinson's disease. Behav Brain Res 2000, 113: 121-129. 10.1016/S0166-4328(00)00207-2View ArticlePubMedGoogle Scholar
- MacDermott AB, Role LW, Siegelbaum SA: Presynaptic ionotropic receptors and the control of transmitter release. Nature Reviews Neuroscience 1999, 22: 443-485.Google Scholar
- Levin E, Wilson W, McEvoy J, Rose J: Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsycopharmacology 1996, 15: 429-436. 10.1016/S0893-133X(96)00018-8View ArticleGoogle Scholar
- Groenewegen HJ, Uylings HB: The prefrontal cortex and the integration of sensory, limbic and autonomic information. Prog Brain Res 2000, 126: 3-28. full_textView ArticlePubMedGoogle Scholar
- Martin SJ, Grimwood PD, Morris RG: Synaptic plasticity and memory: an evaluation of the hypothesis. Annu Rev Neurosci 2000, 23: 649-711. 10.1146/annurev.neuro.23.1.649View ArticlePubMedGoogle Scholar
- Ji D, Lape R, Dani J: Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity. Neuron 2001, 31: 131-141. 10.1016/S0896-6273(01)00332-4View ArticlePubMedGoogle Scholar
- Tallon-Baudry C, Bertrand O, Peronnet F, Pernier J: Induced gamma-b and activity during the delay of a visual short-term memory task in humans. J Neurosci 1998, 18: 4244-4254.PubMedGoogle Scholar
- Bragin A, Jando G, Nadasdy Z, Hetke J, Wise G, Buzsaki G: Gamma (40-100 hz) oscillations in the hippocampus of the behaving rat. J Neurosci 1995, 15: 47-60.PubMedGoogle Scholar
- Whittington MA, Traub RD, Jefferys JGR: Synchronised oscillations in interneuron networks driven by metabotropic glutamate receptor activation. Nature 1995, 373: 612-615. 10.1038/373612a0View ArticlePubMedGoogle Scholar
- Puma C, Deschaux O, Molimard R, Bizot JC: Nicotine improves memory in an object recognition task in rats. Eur Neuropsychopharmacol 1999, 9: 323-327. 10.1016/S0924-977X(99)00002-4View ArticlePubMedGoogle Scholar
- Levin ED, Weber E, Icenogle L: Baclofen Interactions with Nicotine in Rats: Effects on Memory. Pharmacol Biochem Behav 2004, 79: 343-348. 10.1016/j.pbb.2004.08.013View ArticlePubMedGoogle Scholar
- Fries P, Reynolds JH, Rorie AE, Desimone R: Modulation of oscillatory neuronal synchronization by selective visual attention. Science 2001, 29: 1560-1563. 10.1126/science.1055465View ArticleGoogle Scholar
- Gray R, Rajan AS, Radcliffe KA, Yakehiro M, Dani JA: Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 1996,383(6602):713-716. 10.1038/383713a0View ArticlePubMedGoogle Scholar
- Levin ED: Use of the radial-arm maze to assess learning and memory. In Methods in Behavioral Pharmacology. Edited by: Buccafusco JJ. New York: CRC; 2000:189-199.Google Scholar
- Mirza NZ, Bright JL: Nicotine-induced enhancements in the five-choice serial reaction time task in rats are strain-dependent. Psychopharmacology (Berl) 2001, 154: 8-12. 10.1007/s002130000605View ArticleGoogle Scholar
- Shoaib M, Schindler CW, Goldberg SR: Nicotine self-administration in rats: strain and nicotine pre-exposure effects on acquisition. Psychopharmacology (Berl) 1997, 129: 35-43. 10.1007/s002130050159View ArticleGoogle Scholar
- Kumari V, Gray JA, Ffytche DH, Mitterschiffthaler MT, Das M, Zachariah E, Vythelingum GN, Williams SC, Simmons A, Sharma T: Cognitive effects of nicotine in humans: an fMRI study. NeuroImage 2003, 19: 1002-1013. 10.1016/S1053-8119(03)00110-1View ArticlePubMedGoogle Scholar
- Court J, Martin-Ruiz C, Piggott M, Sperden D, Griffiths M, Perry E: Nicotinic receptor abnormalities in alzheimer's disease. Biol Psychiatry 2001, 49: 175-184. 10.1016/S0006-3223(00)01116-1View ArticlePubMedGoogle Scholar
- Ono K, Hasegawa K, Yamada M, Naiki H: Nicotine breaks down preformed alzheimer's beta-amyloid fibrils in vitro. Biol Psychiatry 2002, 52: 880-886. 10.1016/S0006-3223(02)01417-8View ArticlePubMedGoogle Scholar
- Harris JG, Kongs S, Allensworth D, Martin L, Tregellas J, Sullivan B, Zerbe G, Freedman R: Effects of nicotine on cognitive deficits in schizophrenia. Neuropsychopharmacology 2004, 29: 1378-1385. 10.1038/sj.npp.1300450View ArticlePubMedGoogle Scholar
- Allam MF, Campbell MJ, Hofman A, Del Castillo AS, Fernandez-Crehuet Navajas R: Smoking and parkinson's disease: systematic review of prospective studies. Mov Disord 2004, 19: 614-621. 10.1002/mds.20029View ArticlePubMedGoogle Scholar
- Howson AL, Batth S, Ilivitsky V, Boisjoli A, Jaworski M, Mahoney C, Knott VJ: Clinical and attentional effects of acute nicotine treatment in tourette's syndrome. Eur Psychiatry 2004, 19: 102-112. 10.1016/j.eurpsy.2003.11.002View ArticlePubMedGoogle Scholar
- Song C, Murray TA, Kimura R, Wakui M, Ellsworth K, Javedan SP, Lukas RJ, Wu J: Role of alpha7-nicotinic acetylcholine receptors in tetanic stimulation-induced gamma oscillations in rat hippocampal slices. Neuropharmacology 2005, 48: 869-880. 10.1016/j.neuropharm.2005.01.003View ArticlePubMedGoogle Scholar
- Wang K, Zheng C, Wu C, Gao M, Liu Q, Yang K, Ellsworth K, Xu L, Wu J: α-chloralose diminishes γ oscillations in rat hippocampal slices. Neuroscience Letters 2008,441(1):66-71. 10.1016/j.neulet.2008.06.014View ArticlePubMedGoogle Scholar
- Javedan SP, Fisher RS, Eder HG, Smith K, Wu J: Cooling abolishes neuronal network synchronization in rat hippocampal slices. Epilepsia 2002,43(6):574-580. 10.1046/j.1528-1157.2002.40101.xView ArticlePubMedGoogle Scholar
- Pavlides C, Ogawa S, Kimura A, McEwen BS: Role of adrenal steroid mineralocorticoid and glucocorticoid receptors in long-term potentiation in the CA 1 field of hippocampal slices. Brain Research 1996, 738: 229-235. 10.1016/S0006-8993(96)00776-7View ArticlePubMedGoogle Scholar
- Korte M, Carroll P, Wolf E, Brem G, Thoenen H, Bonhoeffer T: Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proceedings of the National Academy of Science: USA 1995, 92: 8856-8860. 10.1073/pnas.92.19.8856View ArticleGoogle Scholar
- Larson J, Wong D, Lynch G: Patterned stimulation at the theta frequency is optimal for the induction of hippocampal long-term potentiation. Brain Research 1986, 368: 347-350. 10.1016/0006-8993(86)90579-2View ArticlePubMedGoogle Scholar
- Pincus SM: Greater signal regularity may indicate increased system isolation math. Bioscience 1994, 44: 122161-81.Google Scholar
- Pincus SM: Approximate entropy as a measure of system complexity. Proceedings of the National Academy of Science 1991, 88: 2297-2301. 10.1073/pnas.88.6.2297View ArticleGoogle Scholar
- Pincus SM, Huang WM: Approximate entropy: statistical properties and applications. Commun Stat - Theory and Methods 1992,21(11):3061-3077. 10.1080/03610929208830963View ArticleGoogle Scholar
- Lipsitz LA, Pincus SM, Morin RJ, Tong S, Eberle LP, Gootman PM: Preliminary evidence for the evolution in complexity of heart rate dynamics during autonomic maturation in neonatal swine. J Auton Nerv Syst 1997, 65: 1-9. 10.1016/S0165-1838(97)00028-3View ArticlePubMedGoogle Scholar
- Swan GE, Lessov-Schlaggar CN: The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychol Rev 2007, 17: 259-273. 10.1007/s11065-007-9035-9View ArticlePubMedGoogle Scholar
- Levin ED, Simon BB: Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology 1998, 138: 217-230. 10.1007/s002130050667View ArticlePubMedGoogle Scholar
- Levin ED, Rezvani AH: Development of nicotinic drug therapy for cognitive disorders. Eur J Pharmacol 2000, 393: 141-146. 10.1016/S0014-2999(99)00885-7View ArticlePubMedGoogle Scholar
- Kem WR: The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of alzheimer's disease: studies with DMXBA (GTS-21). Behav Brain Res 2000, 113: 169-181. 10.1016/S0166-4328(00)00211-4View ArticlePubMedGoogle Scholar
- Nomikos GG, Schilstr B, Hildebrand BE, Panagis G, Grenhoff J, Svensson TH: Role of alpha7 nicotinic receptors in nicotine dependence and implications for psychiatric illness. Behav Brain Res 2000, 113: 97-103. 10.1016/S0166-4328(00)00204-7View ArticlePubMedGoogle Scholar
- Martin LF, Kem WR, Freedman R: Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia. Psychopharmacology 2004, 174: 54-64. 10.1007/s00213-003-1750-1View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.